INTIMATION FOR BODHIKA SEMINAR - 31/08/2022

*BODHIKA SEMINAR FOR 31/08/2022 WILL CONDUCT THREE PRESENTATIONS, 2 FROM THE DEPT OF R&B AND 1 FROM THE DEPT OF SHALYA TANTRA*

DEPARTMENT OF RASA SHASTRA & BHAISHAJYA KALPANA

GOVT. AYURVEDA COLLEGE, THIRUVANANTHAPURAM

NAME  OF  FIRST PRESENTEE: Dr RESMI BABU

THESIS TITLE:MICROBIAL STABILITY OF 

NAYOPAYAM PRAVAHI KWATHA

NAME OF GUIDE: Dr S THARALAKSHMI

DATE:31/08/2022

TIME: 2:00-4:00 PM

VENUE: COLLEGE AUDITORIUM

ABSTRACT

 Pancha vidha Kashaya kalpanas are five basic preparations of Bhaishajya kalpana.and which includes swarasa, kalka, kwatha, hima and phanta.Among them kwatha Kalpana is most significant and widely used dosage form. This is prepared by boiling of herbal drugs with water in a specific proportion .Pravahi kwatha is concentrated kashaya.It is obtained by boiling the ingredients of a specified kwatha churna formulation in a given amount of jala (API part 2 volumes 4).Addition of preservatives in pravahi kwatha is permitted as per API. Nayopayam pravahi kwatha is a decoction prepared with bala, jiraka, shunti in a ratio 10:2:2 (API Part 2 volume 4).Kwatha Kalpana has more chance to get contaminated with microbes as it is an aqueous preparation. Also during boiling of kwatha starch from drugs gets dissolved. Which provides media for the growth of micro organisms leading to its decomposition. Preservatives are used to prevent microbial contamination. As per the thesis “a study on the type and concentration of preservatives used in kwathas by the leading GMP certified companies in kerala” done in Govt. Ayurveda College, Trivandrum, it was noted that the amount of preservatives in kwatha preparation is 10 times more than the permitted limit. So, through a long-term shelf life study, an attempt was made to detect the microbial stability of Nayopayam Pravahi Kwatha with the permitted amount of preservatives using parameters such as microbial contamination, colour, odour, taste, moisture content, pH, specific gravity, and total solid content. An online survey was conducted among the GMP certified companies in kerala preparing concentrated kashayas to collect the details of preservatives in pravahi kwatha. 

 INTIMATION FOR BODHIKA SEMINAR - 24/08/2022

DEPARTMENT OF PRASOOTI TANTHRA AND STREE ROGA

GOVT. AYURVEDA COLLEGE, THIRUVANANTHAPURAM

NAME  OF  FIRST PRESENTEE: Dr PARVATHY S

THESIS TITLE:

EFFECT OF SHILAJATU ON INSULIN RESISTANCE 

IN POLY CYSTIC OVARIAN SYNDROME

NAME OF GUIDE: Dr SHINY S RAJ

NAME OF CO-GUIDE: Dr ANILA M

DATE:24/08/2022

TIME: 2:00-3:00 PM

VENUE: HYBRID / MICROSOFT TEAMS 

ABSTRACT

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder affecting reproductive aged women. It is a hyperandrogenic disorder associated with chronic oligo-anovulation and polycystic ovarian morphology. Insulin resistance and hyper androgenism are considered to be key factors in the etiology of PCOS. Obesity is known to increase circulating androgen and insulin levels, may increase PCOS prevalence and exacerbates the clinical features of PCOS. Since PCOS is an extremely common disorder, PCOS-related insulin resistance is an important cause of GDM and NIDDM  in women. In Ayurveda symptoms of PCOS are often met in diseases like Nashtartava, Artavakshaya, Pushpagni jataharini, prameha and sthoulya. The study drug is Shilajatu, which is known for its pramehagna, sthoulyahara, kaphamedohara property. In the study nineteen Females participants attending the OPD of Prasutitantra and Streeroga, Govt Ayurveda college, Thiruvananthapuram in the age group 18-38 years, fulfilling Rotterdam criteria 2003 and having insulin resistance measured as per HOMA IR value >1were selected. They were given 500mg Shilajatu, morning and evening before food for 90 days. Insulin resistance, menstrual interval, BMI, Waist to hip ratio were assessed before and after treatment. Data obtained was analysed statistically. Study drug was found to be effective in decreasing insulin resistance, reducing menstrual interval, BMI and waist to hip ratio. 

 INTIMATION FOR BODHIKA SEMINAR - 17/08/2022

DEPARTMENT OF PANCHAKARMA

GOVT. AYURVEDA COLLEGE, THIRUVANANTHAPURAM

*THERE WILL BE ONLY ONE PRESENTATION ON 17TH OF AUGUST *

NAME  OF  FIRST PRESENTEE: Dr SWATHI E 

THESIS TITLE: EFFECT OF MADHUTAILIKA YAPANA VASTI IN OLIGOSPERMIA

NAME OF GUIDE: Dr MINI V G

DATE:17/08/2022

TIME: 2:00-3:00 PM

VENUE: HYBRID / MICROSOFT TEAMS 

ABSTRACT

Infertility is defined as a failure to conceive within one or more years of regular unprotected coitus. According to recent report of WHO on status of infertility in India,of all infertility cases ,approximately 50% is due to male factor infertility, owing to the reproductive anomalies in the male. Oligospermia is main contributing factor in it. It is a condition of suboptimal concentration of spermatozoa in the ejaculated semen to ensure successful fertilization of an ovum. ICD 10 Code N46.1 define Oligospermia in human as a sperm count below 20 million per millimeter semen.Oligospermia can be correlated to ksheenasukra in Ayurveda. Ksheenasukra is vata-pita predominant disease. Madhutailika vasti yoga mentioned in Sharangadhara samhita is vrshya and brmhana. Hence the aim of the study was to find out the Effect of Madhutailika yapana vasti in Oligospermia. The study design was pre and post assessment interventional study with a sample size of 15 Male with an age group 25-50 years who are diagnosed having Oligospermia attending IPD of Department of Panchakarma and Department of Kayachikitsa of Govt.Ayurveda college Thiruvanthapuram. Assessment of this study was done with quantitative semen analysis. Participants were administered with Madhutailika yapana vasti for continuous 7 days. Assessment of this study was done with quantitative semen analysis. The result were analyzed with regard to changes in the outcome variable as in semen analysis. The pre and post test data was assessed with Wilcoxon signed rank test. Based on the analysis the study concludes that Madhutailika yapana vasti is effective in Oligospermia.

 INTIMATION FOR BODHIKA SEMINAR - 10/08/2022

DEPARTMENT OF KAYA CHIKITSA

GOVT. AYURVEDA COLLEGE, THIRUVANANTHAPURAM

NAME  OF  FIRST PRESENTEE: Dr ANUPAMA  A S 

THESIS TITLE: EFFECT OF AMRITA GUGGULU AND 

RASNADASAMOOLA KWATHAM IN RHEUMATOID ARTHRITIS

NAME OF GUIDE: Dr PRAVITH N K 

DATE:10/08/2022

TIME: 2:00-4:00 PM

VENUE: HYBRID / MICROSOFT TEAMS 

ABSTRACT

Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown aetiology marked by a symmetric, peripheral polyarthritis. It is peaking between the ages of 35 and 50 and is a chronic disabling condition often causing pain and deformity. Clinically RA is similar to Vatarakta described in our classics. Vata prakopa and Rakta prakopa nidana leads to Raktavritha vata and lodges in Asthi sandhis. The clinical feature of Vatarakta is suggestive of deep dhathugata involvement. As it is an Avaranajanya Vyadhi, different preparations with drugs having Avaranaharatva, Vataanulomana and Rasayana properties are exclusively indicated in the management of Vatarakta. Amrita guggulu and Rasnadasamoola kwatham are two drugs having the above said qualities were selected as a combination to perform in its management.

The study was a before and after study without control group, conducted in Govt.Ayurveda College Hospital, Thiruvananthapuram. 20 patients fulfilling the inclusion and exclusion criteria diagnosed as Rheumatoid arthritis by satisfying the 2010 ACR-EULAR diagnostic criteria were selected and subjected to detailed clinical examination according to clinical research proforma and lab investigations. The study drug Amrita guggulu (500mg) twice daily with lukewarm water one hour after food and Rasnadasamoola kwatham (as sachet) with 60ml lukewarm water twice daily along with 6ml Eranda taila as anupana one hour before food  were given to the study participants for one month. Evaluation was done on 0^th and 31^st day. Statistical analysis reveals that there were significant reduction in subjective and objective parameters. Thus it is recommended that these drugs are effective and safe which can be used in the management of Rheumatoid arthritis.